NCT07211438View on ClinicalTrials.gov

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2026

Primary Completion Date

April 1, 2028

Study Completion Date

December 1, 2028

Conditions
Treatment-Resistant Depression
Interventions
DRUG

Psilocybin

25 mg Psilocybin

Trial Locations (2)

M5T 2S8

Toronto Western Hospital (University Health Network), Toronto

M6J1H4

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
collaborator

University Health Network, Toronto

OTHER

lead

Centre for Addiction and Mental Health

OTHER